Opinions & Features

Pharmaceutical tariffs are looming again, and the stakes are higher than ever.

Is RFK Jr. the answer for U.S. healthcare reform? Dr. Brozak’s Forbes article outlines five key signs that indicate possible major changes under RFK Jr.'s influence.

The musical Lifeline not only entertains but educates on one of the greatest health challenges of our time—antimicrobial resistance. This Forbes article explores how the arts and AI-powered diagnostics are raising awareness and driving change.[...]

It is crucial that we do not continue with a passive, wait-and-see approach, as it is bound to fail. Instead, we must proactively advance a public-private partnership to act now, leveraging public resources, private technology,[...]

Covid-19 has now contributed to two second-term presidential campaigns. In November 2020, when the virus was raging throughout the world, and fears were at their peak, the country sought a return to normalcy – And[...]

Dr. Anthony Fauci has been a key figure in healthcare for nearly 40 years. But healthcare, especially public health, is often not science but the perception of science. That is the dilemma in his memoir[...]

According to Dr Steve Brozak, when AI mixes with illicit drug makers you have a real life “Breaking Bad” His piece on AI-facilitated illicit fentanyl production is a must read:

In his latest Forbes online commentary, Dr. Steve Brozak explains how the Fed’s decision to hold rates will affect U.S. healthcare. In this article, he describes how interest rates are a greater challenge to[...]

In his latest Forbes Online commentary, Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game, Steve Brozak describes how a class of drugs, intended to treat Type 2 diabetes patients, has become a fad drug[...]